Literature DB >> 25647778

Association between some inflammatory markers and primary ovarian insufficiency.

Gülçin Yldrm1, Aytekin Tokmak, Mahmut Kuntay Kokanal, Esma Sarkaya, Cevdet Züngün, Hasan Ali İnal, Fatma Meriç Ylmaz, Nafiye Ylmaz.   

Abstract

OBJECTIVE: This study investigated the discriminative values of neutrophil-to-lymphocyte ratio (NLR), serum amyloid A protein (SAA), and C-reactive protein (CRP) in cases of primary ovarian insufficiency (POI).
METHODS: A total of 84 women were included in this comparative cross-sectional study. The study group consisted of 43 women diagnosed as having POI, and the control group consisted of 41 women with normal fertility. After obtaining a written informed consent form from all participants, we retrieved clinical and demographic data and laboratory findings from the participants and the hospital database. The following variables were analyzed: age, body mass index, smoking, family history, comorbidities, sonographic findings, complete blood count, baseline hormone levels, CRP, and SAA.
RESULTS: NLR was significantly lower in the study group than in the control group (mean [SD], 1.3 [0.7] vs 2.0 [0.7]; P < 0.001). The mean SAA level was 151.6 ng/mL (range, 48.5-12,554.7 ng/mL) in the study group and 147.8 ng/mL (range, 29.8-3,760.4 ng/mL) in the control group (P > 0.05). There was no significant difference in serum CRP levels between two groups (P > 0.05). Receiver operating characteristic analysis revealed that NLR, but not SAA and CRP, was a significantly discriminative parameter for POI (area under the curve, 0.829; P < 0.001). Multivariate logistic regression analysis showed that a family history of POI, smoking, and NLR of 1.5 or less were independent risk factors for POI.
CONCLUSIONS: SAA and CRP do not seem to be valuable discriminative markers for POI, whereas NLR may be a significant promising marker before presentation or in the early stages of POI and may be useful for developing appropriate fertility treatment options.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25647778     DOI: 10.1097/GME.0000000000000423

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  7 in total

Review 1.  Update on primary ovarian insufficiency.

Authors:  Meghan Hewlett; Shruthi Mahalingaiah
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-12       Impact factor: 3.243

2.  Diagnostic Accuracy of Salivary aMMP-8 Test in Infertile Women and Blood Finding Analysis.

Authors:  Lada Šumilin; Larisa Musić; Ivan Puhar; Ivan Sabol; Ivana Japirko; Krunoslav Kuna; Brzak Božana Lončar
Journal:  Acta Stomatol Croat       Date:  2022-06

3.  Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.

Authors:  Ilhan Sanverdi; Cetin Kilicci; Ebru Cogendez; Cigdem Abide Yayla; Enis Ozkaya
Journal:  J Clin Lab Anal       Date:  2017-12-15       Impact factor: 2.352

4.  A prospective study of inflammatory biomarker levels and risk of early menopause.

Authors:  Elizabeth R Bertone-Johnson; JoAnn E Manson; Alexandra C Purdue-Smithe; Susan E Hankinson; Bernard A Rosner; Brian W Whitcomb
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

5.  There is No Association between Premature Ovarian Insufficiency and Levels of Fetuin-A/α2-Heremans-Schmid Glycoprotein.

Authors:  A Seval Ozgu-Erdinc; Zeynep Asli Oskovi Kaplan; Yaprak Engin-Ustun; Nafiye Yilmaz; Gulcin Yildirim; Aytekin Tokmak; Kudret Erkenekli; Salim Erkaya; Dilek Uygur
Journal:  J Hum Reprod Sci       Date:  2019-12-17

6.  High-sensitivity C-reactive protein is not independently associated with self-reported infertility in National Health and Nutrition Examination Survey 2015-2018 data.

Authors:  Rasha A Al-Lami; Shaden A Taha; Randa J Jalloul; Hugh S Taylor
Journal:  F S Rep       Date:  2021-12-18

7.  Evaluation inflammatory markers of hemogram parameters in primary ovarian insufficiency.

Authors:  Bülent Demir; Süreyya Sarıdaş Demir; Kübra Özkan Karacaer; Semir Paşa; Fatma Sılan
Journal:  Turk J Obstet Gynecol       Date:  2020-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.